›WSES and JAMA guidance
›First line regimens
›Cefoxitin IV
›2 g IV preoperatively
›Covers gram negatives and anaerobes
›Cefazolin plus metronidazole
›Cefazolin 2 g IV
›Metronidazole 500 mg IV
›Cefotetan IV
›2 g IV preoperatively
›Alternative cephamycin
›If severe beta lactam allergy
›Ciprofloxacin plus metronidazole
›Ciprofloxacin 400 mg IV
›Metronidazole 500 mg IV
›Aztreonam plus metronidazole
›Aztreonam 2 g IV
›Metronidazole 500 mg IV
›Laparoscopic appendectomy
›Gold standard and procedure of choice
›Shorter hospitalization 2.6 versus 3.4 days
›Earlier return to activity 14 versus 21 days
›Lower surgical site infection
›48 to 70 percent decrease versus open
›Shorter parenteral analgesia duration
›Timing flexibility
›Safe delay within 24 hours
›No increased adverse outcomes
›Open appendectomy
›Reserved indications
›Extensive adhesions
›Hemodynamic instability precluding laparoscopy
›Conversion considerations
›Difficult anatomy
›Inability to identify appendix
Nonoperative and complicated management
›Antibiotic-only therapy
›Selected uncomplicated appendicitis
›Approximately 60 percent treated successfully
›Acknowledged safe option in guidelines
›Typical regimen
›Ertapenem 1 g IV daily initial
›Followed by oral cefdinir and metronidazole 7 to 10 days
›Appendicolith reduces success
›Appendectomy rate 41 versus 25 percent
›Complication rate 20.2 versus 3.5 percent
›If no improvement within 48 hours, appendectomy
›Worsening symptoms
›Diffuse peritonitis or sepsis
›Complicated appendicitis
›Appendiceal abscess in stable patient
›Percutaneous drainage plus antibiotics
›Avoids immediate difficult surgery
›Postoperative antibiotics in complicated disease
›Short course 2 to 3 days
›De escalation based on cultures